Titles:

• Vice Director of the Pancreas center (Pancreas Surgery)
• Chief physicianProfessor and Ph.D. supervisor of Southern Medical University
• Professor and Ph.D. supervisor of South China University of Technology

Specialties:

• Department of General Surgery
• Pancreas center (Pancreas Surgery)

Clinical Interests: Dr. Hou specializes in various kinds of pancreatic and hepatobiliary diseases and possesses abundant experience in the diagnosis and treatment of pancreatic tumor and malignancies. Dr. Hou has a wide range of expertise, including Pancreatic Tumors, Pancreatic Cancer, Pancreatic Surgery, Laparoscopic Pancreas Surgery, Pancreaticoduodenectomy, Laparoscopic Pancreaticoduodenectomy, Whipple Procedure, Cholangiocarcinoma, Bile Duct Cancer, Biliary Tract Surgery, Hepatobiliary Malignancies, Hepatobiliary Surgery, Hepatic Surgery, Hepatocellular Cancer, Hepatopancreatobiliary Surgery, Laparoscopic Gallbladder Surgery, and Gallbladder Cancer, General Surgery.

Experience: In 2012, Dr. Hou studied in the Pancreas Center in Right Bank Hospital of Technical University of Munich, Germany, as well as being a fellow of Professor Hans G. Beger of Surgical Hospital of University of Ulm, Germany.

Education: Dr. Hou received his undergraduate degree in Zhengzhou University Medical School. He gained M.D. majoring in general surgery and Ph.D. majoring in clinical anatomy at First Military Medical University of the Chinese People's Liberation Army. He completed his residency at the 460 Hospital of the People's Liberation Army. Dr. Hou joined Guangdong Provincial People`s Hospital faculty in 2002 as an attending doctor.

Awards and Honors:

• e 4th "Good Doctor of Guangzhou city" in 2018
• The second prize of Science and Technology of Guangdong Province in 2010, participant
• Third prize of Science and Technology of Guangdong Province in 2004, participant
• The second prize of Military Medical Achievements in 2004, participant

Professional memberships: Dr. Hou is a member of several professional organizations.

• The Chairman of Pancreatic Surgeons Branch of Guangdong Medical Doctor Association
• Chairman designate of Pancreatic Cancer Committee of Guangdong Anti-Cancer Association
• The Vice-Chairman of Digital Medicine Branch of Guangdong Medical Association
• The Vice-Chairmen of Hepatobiliary surgery Branch of Guangzhou Medical Association
• A committee member of Neuroendocrine Tumor Branch of China Association for the Promotion of International Exchange of Medical and Health Care
• A member of Neuroendocrine Oncology Group of Pancreatic Cancer Committee of China Anti-Cancer Association

Publications:

• Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer. J Cell Mol Med. 2020;00:1-13.
• Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol. 2020 May 21;26(19):2305-2322.
• YTHDF2 Promotes the Liver Cancer Stem Cell Phenotype and Cancer Metastasis by Regulating OCT4 Expression via m6A RNA Methylation. Oncogene 39: 4507-4518.
• LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.J Cell Physiol. 2019 Aug;234(10):18825-18836.
• Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. J Cell Mol Med. 2020 May;24(9): 5028-5038.